HNL — Dr Hoenle AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €120.63m
- €167.32m
- €106.34m
- 50
- 25
- 57
- 37
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 16.9 | 7.85 | -0.608 | -11.5 | -11 |
Depreciation | |||||
Non-Cash Items | -0.197 | 0.809 | 4.02 | 10.8 | 11.3 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.07 | -8.03 | -15.8 | -21.1 | -7.16 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 16.9 | 7.23 | 1.13 | -7.41 | 3.14 |
Capital Expenditures | -19.3 | -30.2 | -17.1 | -4.31 | -2.93 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.142 | -0.543 | -7.41 | 2.62 | 5.58 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19.1 | -30.7 | -24.5 | -1.69 | 2.65 |
Financing Cash Flow Items | -0.061 | 0.056 | 0 | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.68 | 43.3 | 1.25 | 3.73 | -3.42 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.54 | 19.6 | -22.1 | -4.94 | 2.19 |